188 related articles for article (PubMed ID: 11171211)
1. Metabolism of farnesyl diphosphate in tobacco BY-2 cells treated with squalestatin.
Hartmann MA; Wentzinger L; Hemmerlin A; Bach TJ
Biochem Soc Trans; 2000 Dec; 28(6):794-6. PubMed ID: 11171211
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of squalene synthase and squalene epoxidase in tobacco cells triggers an up-regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase.
Wentzinger LF; Bach TJ; Hartmann MA
Plant Physiol; 2002 Sep; 130(1):334-46. PubMed ID: 12226513
[TBL] [Abstract][Full Text] [Related]
3. Squalene synthase inhibition alters metabolism of nonsterols in rat liver.
Keller RK
Biochim Biophys Acta; 1996 Oct; 1303(3):169-79. PubMed ID: 8908150
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of squalene synthase but not squalene cyclase prevents mevalonate-mediated suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis at a posttranscriptional level.
Peffley DM; Gayen AK
Arch Biochem Biophys; 1997 Jan; 337(2):251-60. PubMed ID: 9016820
[TBL] [Abstract][Full Text] [Related]
5. Regulation of rat hepatic cytochrome P450 expression by sterol biosynthesis inhibition: inhibitors of squalene synthase are potent inducers of CYP2B expression in primary cultured rat hepatocytes and rat liver.
Kocarek TA; Kraniak JM; Reddy AB
Mol Pharmacol; 1998 Sep; 54(3):474-84. PubMed ID: 9730906
[TBL] [Abstract][Full Text] [Related]
6. Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver.
Keller RK; Zhao Z; Chambers C; Ness GC
Arch Biochem Biophys; 1996 Apr; 328(2):324-30. PubMed ID: 8645011
[TBL] [Abstract][Full Text] [Related]
7. Massive production of farnesol-derived dicarboxylic acids in mice treated with the squalene synthase inhibitor zaragozic acid A.
Vaidya S; Bostedor R; Kurtz MM; Bergstrom JD; Bansal VS
Arch Biochem Biophys; 1998 Jul; 355(1):84-92. PubMed ID: 9647670
[TBL] [Abstract][Full Text] [Related]
8. A highly conserved signal controls degradation of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase in eukaryotes.
Gardner RG; Hampton RY
J Biol Chem; 1999 Oct; 274(44):31671-8. PubMed ID: 10531376
[TBL] [Abstract][Full Text] [Related]
9. Role of Phosphatidic Acid Phosphatase Domain Containing 2 in Squalestatin 1-Mediated Activation of the Constitutive Androstane Receptor in Primary Cultured Rat Hepatocytes.
Pant A; Kocarek TA
Drug Metab Dispos; 2016 Mar; 44(3):352-5. PubMed ID: 26700959
[TBL] [Abstract][Full Text] [Related]
10. HMG-CoA reductase regulation: use of structurally diverse first half-reaction squalene synthetase inhibitors to characterize the site of mevalonate-derived nonsterol regulator production in cultured IM-9 cells.
Petras SF; Lindsey S; Harwood HJ
J Lipid Res; 1999 Jan; 40(1):24-38. PubMed ID: 9869647
[TBL] [Abstract][Full Text] [Related]
11. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression by sterols and nonsterols in rat liver.
Ness GC; Eales S; Lopez D; Zhao Z
Arch Biochem Biophys; 1994 Feb; 308(2):420-5. PubMed ID: 8109970
[TBL] [Abstract][Full Text] [Related]
12. Compensatory responses to inhibition of hepatic squalene synthase.
Lopez D; Chambers CM; Keller RK; Ness GC
Arch Biochem Biophys; 1998 Mar; 351(2):159-66. PubMed ID: 9514656
[TBL] [Abstract][Full Text] [Related]
13. Effects of farnesyl pyrophosphate accumulation on calvarial osteoblast differentiation.
Weivoda MM; Hohl RJ
Endocrinology; 2011 Aug; 152(8):3113-22. PubMed ID: 21586555
[TBL] [Abstract][Full Text] [Related]
14. Protein farnesyltransferase: measurement of enzymatic activity in 96-well format using TopCount microplate scintillation counting technology.
Harwood HJ
Anal Biochem; 1995 Apr; 226(2):268-78. PubMed ID: 7793628
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cholesterol 7 alpha-hydroxylase expression by sterols in primary rat hepatocyte cultures.
Doerner KC; Gurley EC; Vlahcevic ZR; Hylemon PB
J Lipid Res; 1995 Jun; 36(6):1168-77. PubMed ID: 7665995
[TBL] [Abstract][Full Text] [Related]
16. Mevalonate-derived isopentenyl diphosphate is the biosynthetic precursor of ubiquinone prenyl side chain in tobacco BY-2 cells.
Disch A; Hemmerlin A; Bach TJ; Rohmer M
Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):615-21. PubMed ID: 9531505
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological control of biosynthesis pathway of mevalonate: effect on the proliferation of arterial smooth muscle cells].
Corsini A; Arnaboldi L; Quarato P; Ferri N; Granata A; Fumagalli R; Paoletti R
C R Seances Soc Biol Fil; 1997; 191(2):169-94. PubMed ID: 9255346
[TBL] [Abstract][Full Text] [Related]
18. Farnesyl pyrophosphate inhibits epithelialization and wound healing through the glucocorticoid receptor.
Vukelic S; Stojadinovic O; Pastar I; Vouthounis C; Krzyzanowska A; Das S; Samuels HH; Tomic-Canic M
J Biol Chem; 2010 Jan; 285(3):1980-8. PubMed ID: 19903814
[TBL] [Abstract][Full Text] [Related]
19. Mevalonic acid-dependent degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vivo and in vitro.
Correll CC; Edwards PA
J Biol Chem; 1994 Jan; 269(1):633-8. PubMed ID: 8276863
[TBL] [Abstract][Full Text] [Related]
20. Identification of farnesol as the non-sterol derivative of mevalonic acid required for the accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Correll CC; Ng L; Edwards PA
J Biol Chem; 1994 Jul; 269(26):17390-3. PubMed ID: 8021239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]